Swelling was also accompanied with pain in the involved region. towards BCAC of the tongue. The goal of this statement is to increase awareness of this rare disease and to evaluate and discuss the differential diagnosis and important considerations in treatment. Keywords:basal cell adenocarcinoma, minor salivary gland, tongue == Introduction == Basal cell adenocarcinomas (BCAC) are slow-growing tumours that most generally involve the parotid gland and very rarely involve the minor salivary glands of the oral cavity.1The average age of patients is 60 years, with no sex predilection.2We present a case of basal cell Pulegone adenocarcinoma in the tongue in a 65 year aged male. Such a presentation is extremely rare. BCAC is believed to arise from pluripotent ductal reserve cells. Histopathology of BCAC is usually characterized by two cell types: small basaloid epithelial cells at the periphery of tumour clusters, and larger epithelial cells situated centrally in tumour clusters. Different histological growth patterns are seen, ie, solid, trabecular, tubular and membranous types. Criteria for the diagnosis of BCAC include infiltrative growth with possible perineural or vascular invasion. Differential diagnosis with high grade malignancies like adenoid cystic carcinoma is usually important because of the low malignant behaviour and good prognosis of BCAC. Immunohistochemistry reveals reactivity for cytokeratins, p53 and focally reactive for epithelial Pulegone membrane antigen and S100 protein. It metastasizes seldom, but may recur locally. Although BCAC is usually a malignant counterpart of Basal Cell Adenoma, it often grows denovo. == Case Presentation == A 65-12 months aged male reported with swelling in the throat for two months. Swelling was also accompanied with pain in the involved region. On examination, Pulegone an ulceroproliferative growth was noticed in the posterior one-third of the tongue extending into the vallecula and crossing the midline. No lymph nodes in the neck were recognized. Radiography revealed no abnormality. Imaging studies revealed no evidence of tumour elsewhere in the body. Wide surgical excision with total removal of the tumour was performed. The surgical specimens were formalin-fixed and paraffin embedded. The sections were stained with routine Hematoxylin and Eosin stain. Special staining were performed including PAS-diastase and Mucicarmine. Immunohistochemistry was performed using avidin biotin complex technique and diaminobenzidine as chromogen. The antibodies used included Pancytokeratin, Pulegone Rabbit Polyclonal to CACNG7 Epithelial Membrane Antigen, p53, Easy Muscle mass Actin, and S-100, at suggested dilution. We also performed appropriate routinely positive and negative controls. == Results == Macroscopically, the biopsy specimen consisted of a single irregular soft tissue bit measuring 1 0.8 0.4 cm, gray-tan in colour and firm in regularity. Microscopically, the section showed ulceration through the mucosa. Variable sized and shaped, nests and linens of basaloid epithelial cells having hyperchromatic to vesicular nuclei (Fig. 1) were seen. Two types of basaloid cells were observed: dark basophilic cells towards periphery and pale basophilic cells towards centre from the proliferation. Nuclear palisading was noticed along the user interface using the collagenous stroma. Intervening heavy rings of collageous septa had been noticed. Tumour demonstrated an infiltrative development design and focal regions of squamous cell differentiation. Mitotic activity was noticed. No salivary gland cells was determined in the areas studied. Mucicarmine and PAS-diastase were bad. == Shape 1. == Histologic appearance of solid/trabecular nests of cells with scant cytoplasm, vesicular nuclei and peripheral palisading. Overlying squamous epithelium sometimes appears. Arrow shows vascular invasion. Eosin and Hematoxylin stain, magnification 100. Immunohistochemical evaluation exposed Pancytokeratin (Fig. 2), Epithelial Membrane Antigen, p53 (Fig. 3) and S100 positivity. On the other hand, Smooth Muscle tissue Actin (SMA) was adverse. == Shape 2. == Immunohistochemical staining displaying diffuse positivity for cytoplasmic antigen Pancytokeratin (200). == Shape 3. == Improved proliferation recognized by p53 immunostain. Magnification (100). The medical presentation as well as the macroscopic element, using the histological design collectively, the cytological features and the mobile immunophenotype dealt with the analysis towards Basal Cell Adenocarcinoma (solid design blended with trabecular design), in the tongue. == Dialogue == Basal cell adenocarcinoma (BCAC) was initially recognized in 1978.3Ellis and Gnepp defined the histological features of BCAC in 1988 initial. The clinic-pathologic top features of this tumour were defined in 1990 by Wiscivitch and Ellis in.